Carregant...
Repair of 3-methyladenine and abasic sites by base excision repair mediates glioblastoma resistance to temozolomide
Alkylating agents have long played a central role in the adjuvant therapy of glioblastoma (GBM). More recently, inclusion of temozolomide (TMZ), an orally administered methylating agent with low systemic toxicity, during and after radiotherapy has markedly improved survival. Extensive in vitro and i...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3515961/ https://ncbi.nlm.nih.gov/pubmed/23230562 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2012.00176 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|